• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Pain Management in Acute Gout: NSAIDs or COX-2 Inhibitors?


A recent meta-analysis assessed comparative clinical efficacy of NSAIDs and COX-2 inhibitors. Try these 7 questions on the findings - does your clinical experience match?


A 2020 meta-analysis published in BMJ Open assessed the comparative clinical efficacy of traditional non-selective NSAIDs and selective COX-2 inhibitors in patients with acute gout.

The main outcome measures included were mean change in pain Visual Analogue Scale score and 5-point Likert scale score on days 2–8. All of the following questions and answers are based on findings from this meta-analysis.

Do the analysis results match your experience in clinical practice?

Note: the meta-analysis did not include naproxen for comparisons, due to a lack of clinical trials. The analysis also did not include comparison to colchicine or corticosteroids.

1. Which of the following offers a clear advantage in terms of pain scores in acute gout?

A. Etoricoxib

B. Celecoxib

C. Meloxicam

D. Ibuprofen

© 2024 MJH Life Sciences

All rights reserved.